SciELO - Scientific Electronic Library Online

 
vol.67 issue4Stereotactic biopsy for intracranial lesions: clinical-pathological compatibility in 60 patientsClinical features of multiple sclerosis in the south of Brazil: a partial analysis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Arquivos de Neuro-Psiquiatria

Print version ISSN 0004-282X

Abstract

BONDAN, Eduardo Fernandes et al. Ethidium bromide-induced demyelination in the sciatic nerve of diabetic rats. Arq. Neuro-Psiquiatr. [online]. 2009, vol.67, n.4, pp. 1066-1070. ISSN 0004-282X.  http://dx.doi.org/10.1590/S0004-282X2009000600020.

This study aims to observe the process of myelin loss and repair following the injection of the gliotoxic agent ethidium bromide (EB) in the sciatic nerve of rats previously induced to diabetes mellitus by streptozotocin. Injection of EB was also done in non-diabetic rats. The animals were euthanatized from 3 to 31 days after intraneural injection and nerve sections were collected for ultrastructural study. In non-diabetic rats, Schwann cells (CS) showed signs of intoxication 3 days after, with cytoplasmic vacuolization and rejection of their myelin sheaths. Myelin debris were removed by macrophages in the endoneurium and mast cells were abundant in the lesions. From 14 days following EB injection, supernumerary CS were seen in the expanded endoneurium as well as thin myelin sheaths indicating remyelination. Diabetic rats presented a more extensive myelin vesiculation and segmentar demyelination, with delayed activities from both macrophages and remyelinating SC. No mast cells were noted.

Keywords : demyelination; diabetes mellitus; ethidium bromide; peripheral nervous system; remyelination; Schwann cells.

        · abstract in Portuguese     · text in English     · pdf in English